Fig. 1From: Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormoneStudy design and groups. B-1: 1 year before burosumab initiation, B0: initiation of burosumab therapy, B1: 1 year after burosumab initiation, GH0: initiation of rhGH therapy, GH-1: 1 year before rhGH initiation, GH1: 1 year after rhGH initiationBack to article page